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Microbiome–Gut–Brain axis:  
a pathway for improving Brainstem 
serotonin Homeostasis and 
successful autoresuscitation in 
sids—a novel Hypothesis
Vijayakumar Praveen1* and Shama Praveen2
1 Kaiser Permanente South Bay, Harbor City, CA, USA, 2 Providence Little Company of Mary Medical Center,  
Torrance, CA, USA
Sudden infant death syndrome (SIDS) continues to be a major public health issue. 
Following its major decline since the “Back to Sleep” campaign, the incidence of SIDS 
has plateaued, with an annual incidence of about 1,500 SIDS-related deaths in the United 
States and thousands more throughout the world. The etiology of SIDS, the major cause 
of postneonatal mortality in the western world, is still poorly understood. Although sleep-
ing in prone position is a major risk factor, SIDS continues to occur even in the supine 
sleeping position. The triple-risk model of Filiano and Kinney emphasizes the interaction 
between a susceptible infant during a critical developmental period and stressor/s in the 
pathogenesis of SIDS. Recent evidence ranges from dysregulated autonomic control 
to findings of altered neurochemistry, especially the serotonergic system that plays an 
important role in brainstem cardiorespiratory/thermoregulatory centers. Brainstem sero-
tonin (5-HT) and tryptophan hydroxylase-2 (TPH-2) levels have been shown to be lower 
in SIDS, supporting the evidence that defects in the medullary serotonergic system play 
a significant role in SIDS. Pathogenic bacteria and their enterotoxins have been associ-
ated with SIDS, although no direct evidence has been established. We present a new 
hypothesis that the infant’s gut microbiome, and/or its metabolites, by its direct effects 
on the gut enterochromaffin cells, stimulates the afferent gut vagal endings by releasing 
serotonin (paracrine effect), optimizing autoresuscitation by modulating brainstem 5-HT 
levels through the microbiome–gut–brain axis, thus playing a significant role in SIDS 
during the critical period of gut flora development and vulnerability to SIDS. The shared 
similarities between various risk factors for SIDS and their relationship with the infant 
gut microbiome support our hypothesis. Comprehensive gut-microbiome studies are 
required to test our hypothesis.
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introdUCtion
Sudden infant death syndrome (SIDS) is defined as a sudden 
unexplained death in the first year of life in a previously healthy 
infant, where the cause of death remains unidentified despite 
thorough investigations including a complete autopsy, death 
scene investigation, and review of clinical history (1). SIDS is a 
major cause of postneonatal infant mortality in the western world. 
In the United States, ~1,500 infants died of SIDS in 2013 alone, 
despite the steady reduction (1994–2000) in such deaths since the 
“Back to Sleep” campaign. The incidence of SIDS has remained 
fairly constant in the last decade, while the rate of other causes 
of ill-defined, unspecified, and sudden unexpected infant deaths 
has increased (1, 2). Some infant deaths, which would have been 
classified as SIDS in the past, are now being classified as resulting 
from suffocation and asphyxia. The significant reduction in SIDS 
rate in the past 20 years may be related to increasing diagnoses of 
other causes of death (1). Japan and the Netherlands have the low-
est SIDS rates, at 0.09 and 0.1 per 1,000 live births, respectively, 
whereas New Zealand has the highest reported SIDS rate (0.8 per 
1,000 live births) (3–6). The United States and UK have SIDS rates 
of 0.57 and 0.41 per 1,000 live births, respectively (7, 8). Prone 
sleeping position, a significant SIDS risk factor, cannot be easily 
associated with the other epidemiological risk factors related to 
SIDS (9).
Current Hypotheses for sids
Sudden infant death syndrome is a condition without a widely 
accepted singular pathological mechanism.
(1) Triple-risk model: this model proposes that SIDS occurs when 
external stressors simultaneously act upon on a susceptible 
infant with a vulnerable homeostatic system during a critical 
developmental period (10).
(2) Failed autoresuscitation: animal studies have shown that car-
diorespiratory, sleep, and arousal mechanisms are abnormal 
following exposure to risk factors associated with SIDS or in 
infants who later succumb to SIDS (11, 12). Although the 
exact cause of SIDS is unknown, immaturity of brain stem 
autonomic cardiorespiratory/thermoregulatory control 
and failure of autoresuscitation during sleep are significant 
determinants of survival (11, 12). A leading SIDS hypothesis 
states that a structural/neurochemical brainstem abnormal-
ity results in failure of autoresuscitation following exposure 
to a stressor during a critical developmental period (13, 14). 
SIDS vulnerability is specific to failed autoresuscitation from 
an adverse autonomic event (AAE). The initial self-initiated 
gasp during such an event is dependent of optimal serotonin 
homeostasis in the brain, which is undermined in SIDS. 
Imbalance in serotonin homeostasis alters sleep rhythm, thus 
increasing the chances of AAE (15).
(3) Medullary serotonergic network deficiency: SIDS is associ-
ated with multiple serotonergic defects including serotonin 
deficiency (16–19). It has been associated with reduced 
serotonin in the ventral medulla, pointing to a brainstem-
based autonomic dysfunction affecting sleep/arousal/
cardiorespiratory reflexes (20–23). Gene polymorphisms 
related to serotonergic autonomic system may play a role 
in SIDS (24). In a recent study in neonatal rodents, loss of 
brain stem 5HT may explain the cardiovascular collapse 
during apparent severe hypoxic event in some SIDS cases 
(25). Recent neuropathology studies in SIDS implicate 
defective neurotransmitter function in the medullary arcu-
ate nucleus, receptor immaturity of the “respiratory center” 
nucleus tractus solitarius (NTS), and defective function of 
the serotonergic raphé nuclei of the ponto-medullary ventral 
median septum and other brainstem serotonergic neurons 
(26). Abnormalities of the dorsal motor nucleus of the vagus 
(DMNV) have been associated with SIDS (27). In a sig-
nificant number of SIDS infants, cerebellar dentate nucleus 
lesions may represent a developmental susceptibility leading 
to autonomic cardiorespiratory/arousal dysfunction and 
sleep-related death when exposed to homeostatic stressors 
(28). Cummings et al. report that, in addition to respiratory 
and cardiac dysfunction in normoxemic conditions, neona-
tal mice with reduced (by 60–70%) brainstem serotonergic 
neurons from early embryogenesis onward (Pet-1−/−) have 
major defects in autoresuscitation, a life-preserving process 
utilized by neonatal mammals in severely hypoxic conditions 
(29–33).
(4) Neurotransmitters: neurotransmitter systems (e.g., cholin-
ergic and GABA-ergic) have been shown to be involved in 
SIDS (34, 35). Reduced muscarinic cholinergic binding in 
the medullary arcuate nucleus (involved in cardiorespira-
tory control) has been shown to occur in SIDS (34). GABA 
neurons in the medulla help regulate homeostasis through 
interactions with the medullary serotonergic system (35). 
Significant decrease in GABA A receptor binding was found 
in the medullary serotonergic system in SIDS cases associ-
ated with 5-HT defects (35).
neW HypotHesis
We propose a new hypothesis that the infant gut microbiome 
plays an important role in SIDS during the period critical to both 
gut flora maturation/development and vulnerability to SIDS, by 
modulating brainstem serotonergic system through the bidi-
rectional microbiome–gut–brain axis, thus tilting the balance 
in favor of successful autoresuscitation during a sleep-related 
AAE. The components of our hypothesis, though individually 
and separately studied in the past, have never been put together 
as the structure of a SIDS hypothesis. The factors protective 
against as well as the risk factors of SIDS show some compel-
ling circumstantial evidence of their effects on gut microbiome 
leading to beneficial and dysbiotic infant gut flora, respectively, 
with corresponding effects on brainstem serotonergic system. 
The plausibility of such an SIDS hypothesis would open up a 
new paradigm for preventative and therapeutic approaches in 
SIDS. Our hypothesis is the only one till date, which connects 
the protective/risk factors of SIDS with infant gut flora, their 
effect via microbiome–gut–brain axis on brainstem seroton-
ergic system, and subsequent successful autoresuscitation 
(Figure 1).
FiGUre 1 | new sudden infant death syndrome hypothesis pathway: effect on infant gut flora on brainstem serotonin homeostasis and 
autoresuscitation via microbiome–gut–brain axis.
3
Praveen and Praveen Microbiome–Gut–Brain Axis in SIDS
Frontiers in Pediatrics | www.frontiersin.org January 2017 | Volume 4 | Article 136
Microbiome–Gut–Brain axis
The human adult gut has about 1014 microorganisms, 10-fold the 
human cells and 150-fold the amount of human DNA (36, 37). 
The human gut microbiome comprises more than 1,000 species, 
predominantly obligate anaerobes, and includes viruses, proto-
zoa, archaea, and fungi (36–39). Gastrointestinal homeostasis 
has a significant role in the human general health and well-being 
(39–41). The concept of the brain–gut axis involves the complex 
bidirectional homeostatic neuronal communication through the 
vagus nerve that exists between the central nervous system (CNS) 
and the enteric nervous system (ENS) (42). Current research 
studies the mechanism of such communication along this axis 
and its relationship to normal homeostasis and disease states 
(42–48). The basic skeleton of the microbiome–gut–brain axis 
includes gut microbiome, the CNS, neuroendocrine and neuro-
immune systems, ENS, sympathetic, and parasympathetic arms 
of the autonomic nervous system (49). The gut accounts for 95% 
of the body’s serotonin content. The detailed structure, integra-
tion, and functioning of the various components of the above axis 
have been reviewed extensively elsewhere (45).
Gut microbial colonization also plays a major role in the 
postnatal development of the endocrine and immune systems, 
which in turn support CNS function, particularly the develop-
ing serotonergic system (41, 42, 50–52). Neurotransmitters, 
neurohormones, and receptors are ubiquitous in nature, e.g., 
catecholamines corticotrophin, somatostatin, and GABA derived 
from bacteria (53–56). Evolutionally speaking, bacteria preceded 
humans in developing neurotransmitters and recognizing them 
(57–59). The ontogeny of neurochemicals in mammals has been 
postulated to arise as a consequence of bacterial lateral gene 
transfer (60). Thus, the gut microbiota might have played an 
important role in the evolution of neurodevelopment (61).
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Gut Vagal Afferents and the Medullary Serotonergic 
System
Sudden infant death syndrome is associated with multiple 
serotonergic defects including serotonin deficiency and DMV 
abnormalities (15–18, 62). We briefly review the vagal afferents, 
brainstem respiratory neurons, and the medullary serotonergic 
system.
Vagal afferents outnumber vagal efferents by 10:1, which are 
sensitive to the paracrine effects of the enterochromaffin cells 
(ECC), relay through nodose and dorsal root ganglia before 
synapsing with second-order neurons in the spinal cord, which 
in turn project into the brainstem. The brainstem has major 
respiratory neurons concentrated into three recognizable groups 
comprised of four major nuclei. These include the following: (1) 
dorsal respiratory group (DRG) centered in the NTS; (2) ventral 
respiratory group that encompasses the nucleus ambiguous and 
the nucleus retroambigualis; (3) pre-Botzinger complex (pre-
BotC) which contains putative pacemaker neurons; and (4) BotC 
located in and near the nucleus retrofacialis. The DRG neurons 
through the phrenic neurons in the cervical spinal cord control 
the diaphragm.
The medullary serotonergic system projects to brainstem 
cardiorespiratory nuclei (including the DMNV), cerebellum, 
and spinal cord, thus modulating cardiorespiratory protective 
reflexes, central chemoprotective reflexes, arousal/sleep cycles, 
thermoregulatory reflexes, and maintenance of upper airway 
patency (63).
Vagal afferents affect respiratory control as shown by altered 
respiratory pattern after stimulation of visceral vagal afferents in 
guinea pigs which died within a few hours of bilateral vagotomy; 
their frequency of breathing significantly decreased within 
minutes of the procedure (64, 65). Serotonin may regulate devel-
opmental brainstem neuronal apoptosis with its pro- or antiapop-
totic effects as a result of the receptor sub-family activated (66). 
Animal studies have shown that the highest density of 5-HT3 
receptors are found within the afferent vagal fibers of dorsal 
vagal complex (67, 68) and vagotomy was found to significantly 
reduce receptor density (69–71). Stimulation of the NTS 5-HT3 
receptors leads to elevation of blood pressure and inhibition of 
the chemoreceptor-mediated bradycardia and the Bezold–Jarisch 
reflexes. As an example of sensory neural plasticity, recent rat 
studies have shown that glucose in the intestinal tract probably 
induces serotonin release from neuroendocrine cells, which acti-
vates 5HT3 on vagal afferent terminals and transmitted centrally 
(72–79).
Gut Microbiome affects the Brainstem
There is emerging evidence from animal and clinical studies on 
the role of gut microbiome in CNS signaling.
Animal Studies
Evidence from rodent studies indicates that the gut microbiome 
can affect neural development, chemistry, and behaviors, e.g., 
emotion, pain perception, and stress responses. As rodent 
gut colonization pattern is similar to humans, they are sub-
jects of choice for gut microbiome studies. CNS tryptophan 
concentrations are dependent on peripheral content, which sug-
gests that gut flora might play a part in regulating peripheral and 
central serotonin synthesis (44, 80, 81). TPH2 is responsible for 
the synthesis of serotonin in brainstem raphe nuclei, which is the 
origin of most central serotonergic projections (82). Probiotics 
have been shown to modulate serotonin—a critical central neu-
rotransmitter through multiple strain-specific mechanisms (83). 
Lyte et al. proposed a “delivery system” by which gut flora can 
communicate neurochemical messages to the brain. Gut bacteria 
produce and react to the same neurotransmitters (e.g., serotonin, 
norepinephrine, dopamine, and GABA) that play a role centrally 
in modulation of mood (84). Animal studies studying effects of 
probiotics on CNS function have been extensively and system-
atically reviewed elsewhere (85). In addition, we have listed few 
rodent studies looking at the role of pathogenic bacteria and vagus 
on CNS neurochemistry and behavior (52, 86–92) (Table 1).
Clinical Studies
Emerging evidence from clinical studies in autism indicates a 
relationship between gut flora and cognitive function. Researchers 
have reported gut flora dysbiosis with increases in Clostridium 
spp. in autism (93). A probiotic mixture of Lactobacillus helveticus 
and Bifidobacterium longum for a month has been reported to 
decrease anxiety and depression in healthy human (94). Other 
adult human clinical studies looking at probiotic effects on 
neurobehavior have been systematically reviewed elsewhere (85).
Brain affects Gut Microbiome
Stress induces gut permeability, which allows bacteria/bacte-
rial antigen translocation across the epithelial barrier, thereby 
activating immune response and resulting in changes in the gut 
microbiome characteristics (95). Psychological stressors have 
been reported to modulate infant gut microbiome (47). Prenatal 
stressors have been reported to cause dysbiosis by decreasing gut 
Bifidobacteria and Lactobacilli in infant rhesus monkeys (96). 
In rodent studies, the stress of maternal separation significantly 
decreased stool lactobacilli on the third day, which returned to 
baseline by day 7 following separation (97). Stressors acting on 
an at-risk infant during the critical window period could affect 
the favorable nature of infant gut flora and consequently affect the 
brainstem neurotransmitters through bidirectional communica-
tion and/or gut barrier function locally.
Based on the evidence from the experimental and clinical 
studies discussed above, we propose that an optimal (diversity, 
complexity, and colony counts) gut flora interacts with ECC and 
modulates (possibly by its serotonin and other paracrine effects) 
through the afferent vagal endings to the brain stem medullary 
serotonergic cardiorespiratory centers in infants at risk for SIDS. 
Recent research in microbiome–gut–brain axis supports role of 
probiotics to modulate central brain neurochemistry, thus open-
ing up a site for therapeutic targeting for central brain disorders.
Shared Risk Factors for SIDS and Gut Dysbiosis
In the following section, we report how each of the protective as 
well as risk factors for SIDS seems to offer evidence of promoting 
symbiotic (favorable) and dysbiotic gut (non-favorable) flora, 
taBle 1 | animal studies showing effect of gut microbiome/probiotics on the central nervous system (Cns).
reference study characteristics
1. Sudo et al. 
(86)
Participants: mice study, in vivo. Germ-free (GF) at 9 weeks of age
Intervention: stress protocol
Controls: specific pathogen-free (SPF) BALBc mice, gnotobiotic mice
Primary outcome: plasma ACTH, corticosterone levels, fecal microflora analysis, plasma cytokine assays
Conclusion: plasma ACTH and corticosterone responses of GF mice were more susceptible to stress than those of SPF mice. Gut flora regulates the 
development of the HPA stress response
2. Bravo et al. 
(87)
Participants: adult male BALB/c mice, in vivo (n = 36)
Intervention: Lactobacillus rhamnosus 109 cfu gavaged for 28 days
Control: control broth
Type of probiotic: L. rhamnosus (JB-1)
Primary outcome: corticosterone level, behavioral analysis, GABA B1b mRNA expression in hippocampus, amygdala, and locus coeruleus
Conclusion: L. rhamnosus supplementation reduced corticosterone response to stress and modulated the GABAergic system in mice. Vagotomized 
mice did not show the neurochemical effects of this bacterium
3. Desbonnet 
et al. (88)
Participants: adult Sprauge-Dawley rats (n = 20)
Intervention: Bifidobacterium infantis 35624 gavaged for 14 days (n = 12)
Controls: n = 8
Type of probiotic: B. infantis 35624
Primary outcome: corticosterone level, tryptophan and IFN-g, TNF-alpha and IL-6, brain monoamines analysis
Conclusion: attenuation of pro-inflammatory immune responses and the elevation of the serotonergic precursor, tryptophan, in probiotic-treated group
4. Alenina 
et al. (89)
Participants: Tph2-deficient (Tph2−/−) mice, in vivo study
Intervention: gene targeting leading to mice with absent TPH2, n = 4
Type of probiotic: none
Controls: n = 6
Primary outcome: serotonin in the brain of Tph2−/− mice
Conclusion: the lack of central serotonin in these mice leads to impaired early postnatal growth and altered autonomic control of sleep, 
thermoregulation, and cardiorespiratory reflexes
5. Lyte et al. 
(84)
Participants: 9-week-old CF-1 male mice, in vivo study
Intervention: in an animal model of IBD, infection with Citrobacter rodentium, to determine whether the infection could lead to anxiety-like behavior
Controls: saline
Type of probiotic: none
Primary outcome: tested for anxiety-like behavior measurement, immune cytokine analysis, and colon for histological analysis
Conclusion: C. rodentium infection could induce anxiety-like symptoms that are likely mediated via vagus
6. Gareau 
et al. (90)
Participants: mouse in vivo study
Intervention: behavior was assessed following infection with the non-invasive enteric pathogen, C. rodentium in both C57BL/6 mice and GF Swiss-
Webster mice
Primary outcome: whether daily treatment with probiotics normalized behavior was assessed
Conclusion: memory dysfunction occurred in infected mice exposed to acute stress, while in the GF setting, memory was altered at baseline
7. McVey 
Neufeld et al. 
(91)
Participants: mouse ex vivo study
Intervention: segments of jejunum from 8- to 12-week old GF, SPF, and CONV-GF mice dissected to expose myenteric plexus. Intracellular recordings 
by impaling cells with sharp microelectrodes
Type of probiotic: none
Primary outcome: action potential shapes, firing thresholds, the number of APs fired at 2× threshold, and passive membrane characteristics were 
measured
Conclusion: commensal intestinal microbiota are essential for normal excitability of gut sensory neurons. When the vagus nerve is severed, effects of 
gut bacteria on brain biochemistry, stress response, and behavior disappear
8. Heijtz et al. 
(92)
Participants: mouse in vivo study GF versus SPF mice with normal microbiological gut flora
Intervention: motor activity and anxiety-like behavior measured
Conclusion: unstressed GF mice were more active and willing to explore exposed areas of a maze than mice that had normal gut microbiota. 
Transplanting normal gut bacteria into the GF mice erased those behavioral differences only in early life, suggesting that there is a critical window for 
gut bacteria to establish normal patterns of behavior
9. Clarke 
et al. (52)
Participants: male GF animals compared with conventionally colonized control animals
Intervention: measurement of 5-HT in hippocampus
Male GF animals have a sex-specific significant elevation in hippocampal 5-HT and 5-HIAA compared with conventionally colonized control animals. 
Concentrations of tryptophan, the precursor of serotonin, are increased in the plasma of male GF animals, suggesting a humoral route through which 
the microbiota can influence CNS serotonergic neurotransmission
Conclusion: microbiome–gut–brain axis in early life modulate hippocampal serotonin levels in a gender-dependent manner
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respectively, during the critical window when both SIDS tends 
to occur and early infant gut colonization is being established.
Demographic Factors
(1) Ethnicity: studies in indigenous populations have reported 
a higher SIDS rate compared to the non-indigenous groups 
within the same countries (98). These differences may reflect 
differences in maternal smoking, which could affect fre-
quency and density of colonization of infants by potentially 
pathogenic bacteria and induction/control of inflammatory 
responses (98). Maternal cigarette smoking and/or alcohol 
consumption may contribute to abnormal fetal medullary 
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Frontiers in Pediatrics | www.frontiersin.org January 2017 | Volume 4 | Article 136
5-HT development in Native American SIDS infants (99). A 
recent study has reported diet-related differences in gut flora 
composition between African-Americans and native Africans. 
African-Americans had higher levels of 7-α-dehydroxylating 
bacteria and lower levels of Lactobacillus plantarum (which 
produce methane and is protective against dysbiosis) (100, 
101).
(2) Low socioeconomic status: SIDS has been associated with 
lower socioeconomic groups (102). Fecal lactobacilli num-
bers have been related to socioeconomic status (103). Gut 
flora differences related to diet, smoking status, and access 
to health services could be a proxy for lower socioeconomic 
status.
(3) Gender: SIDS shows a male preponderance. Animal studies 
have shown gender differences in the regulation of seroton-
ergic system (104, 105). Estrogen has been implicated in the 
modulation of hippocampal serotoninergic system (106, 
107). Gender influences gut microbiome (108–111) through 
unclear mechanisms (110) including hormone–microbe 
interactions (111, 112) and gender-specific immune 
responses (113).
(4) Genetic control: genes regulating serotonergic network, brain 
function and development, and cardiac function play an 
important role in SIDS (114). Studying the role of genetics 
on gut microbiome is important in understanding the patho-
genesis of bacterial diseases (115, 116).
Prenatal Risk Factors
(1) Maternal smoking: SIDS is five times more common in 
infants born to mothers who smoked during pregnancy and 
three times more common in those exposed postnatally to 
smoking (117, 118). Cigarette smoke exposure and prone 
sleep position is associated with decreased 5HT1A recep-
tors in the DMNV of SIDS infants (119). A reduction in 
5HT1A receptors has been reported in the DMNV of piglets 
subjected to intermittent hypercapnic hypoxia and nicotine 
exposure (120). A recent study showed that cessation of 
smoking improved gut microbial diversity (121). Smoking 
may play a role in SIDS through its effects on infant gut flora 
and brainstem serotonin homeostasis.
(2) Being overweight: overweight infants and mothers have a 
higher risk of SIDS (122). Obese human adults had less 
Bacteroides and more Firmicutes in their gut flora com-
pared with lean controls (123). A recent review looked at 
maternal obesity-related pro-inflammatory state and its 
effect on maternal and in utero fetal gut microbiome and 
development (124).
(3) Delivery route: infants delivered by cesarean section have an 
increased risk of SIDS than those born by vaginal route (125). 
The mode of delivery has a significant effect on newborn gut 
flora development (126–128). The gut flora in infants born by 
cesarean may be altered till 6 months following delivery (129). 
Prolonged duration of labor during vaginal birth increases 
the chances of isolation of viable microbes from the stomach 
and mouth of the infant (130, 131). In addition to exposure 
to maternal flora, infants born by cesarean section acquire 
gut flora from their exposure to the immediate environment 
(132). Aseptic precautions in obstetrics and neonatal units 
may result in dysbiosis of the infant gut microbiome (133).
Postnatal Risks
(1) Season: SIDS is more common during winter months 
(134). There is an association of a viral infection in the 
days preceding SIDS (135). Stressors such as viral infec-
tions during winter may cause dysbiosis in infants (136). 
Such dysbiosis could play a role in successful autoresusci-
tation via microbiome–gut–brainstem pathway.
(2) Low birth weight: the rate of SIDS is higher in low birth 
weight infants (137). This may be related to the gut colo-
nization patterns of very low birth weight (VLBW) infants 
compared with normal weight infants. In an elegant study, 
the initial gut colonization by Enterobacteria and Strep-
tococci was similar in both VLBW and full-term infants; 
however, both microorganisms predominated for a longer 
period of time and the establishment of Bifidobacterium, 
Bacteroides, Clostridium, and Lactobacillus was delayed in 
VLBW infants (138).
(3) Prone sleep position: prone sleeping position has been the 
most important risk factor associated with SIDS (139). In 
addition to decreased arousal response related to prone 
sleeping, body temperature seems to be slightly elevated 
in prone infants (140, 141). Prone sleep position has been 
associated with Staphylococcus aureus gut colonization in 
SIDS. The increased risk of ingestion/inhalation of bacte-
ria contaminating the sleeping surface during prone po-
sition, with resultant gut dysbiosis, could account for the 
increased risk of SIDS in such infants (22).
(4) Breastfeeding: breastfeeding has been shown to be protec-
tive against SIDS (142, 143). Breast milk oligosaccharides 
when fermented by gut flora to form fatty acids results in 
modulation of infant gut flora. Breast-fed infants show 
predominant proliferation of Bifidobacteria and Lacto-
bacilli, whereas formula-fed infants show more Entero-
cocci and Enterobacteria in their gut flora. In addition, 
infants who are breast-fed exclusively have been repor-
ted to have better sleep arousal patterns than formula-fed 
infants (144).
(5) Elevated or reduced room temperature: overheating of 
infants has been reported with an elevated risk of SIDS 
(2, 145). Animal studies have showed that the presence 
of certain gut flora elevates body temperature of mice 
and rats. Conn et  al. demonstrated that Gram-positive 
organisms are a major source of the stimulatory effect 
of gut flora on normal body temperature in mice (146). 
Body temperature has been shown to have effects on the 
intestinal flora of hibernating squirrels (147, 148). Oral 
antibiotics have been shown to reduce nighttime body 
temperature in rabbits as a result of their effect on their 
native intestinal flora (149). These studies may help in un-
derstanding whether the increased body temperature as a 
risk factor for SIDS could be a result of aberrant gut flora 
or vice versa. Elevated body temperature associated with 
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prone sleep position may also play a role in affecting gut 
flora composition (140, 141).
(6) Pacifier use: pacifier sucking has been shown to be strongly 
associated with the oral colonization of salivary lactoba-
cilli (150). Thus, pacifier use might play a role in favorable 
oral and subsequently gut flora in infants.
(7) Sleep surface, bedding, and stuffed toys: apart from mecha-
nical suffocation and overheating issues, these may act as 
fomites contributing to the infant gut flora. Sherburn et al. 
showed that simulated infant head movements and mat-
tress-related factors affect aerial release of bacteria from 
beds (151).
(8) Co-sleeping: recent meta-analyses showed that bed sharing 
during sleep increases the risk of SIDS, which is further 
increased when combined with parental smoking, ma-
ternal alcohol consumption, and/or drug use (152). The 
results of a Swedish study suggest that parental skin 
S. aureus establish readily in the infant’s gut, perhaps due 
to poor competition from other gut bacteria (153). The 
possible role of acquiring abnormal gut flora from parents/
caregivers skin/gut flora by prolonged close contact during 
bed sharing needs to be investigated further.
(9) Infant’s age: SIDS incidence peaks around 2–4  months 
of the infant’s age, and subsequently decreases by 1 year. 
Infant gut flora develops through a period of instability 
in the early months of infancy and reaches more mature 
adult-like microbiome by 1 year of age, the time by which 
SIDS disappears. Another condition, not fully explained, 
affecting the infant during a typical window period is in-
fant colic, in which aberrant gut flora has been recently 
shown to play a role, amenable to probiotics. Infantile co-
lic is associated with a greater extent with near-miss SIDS 
infants than among control infants, thereby hypothesizing 
that colic might play a role as a protective arousal me-
chanism in such infants (154). From infection/immuni-
ty standpoint, this is the time when maternal antibodies 
reach their nadir making infants more susceptible to in-
fections, including from indigenous pathogenic gut flora. 
Introduction of supplementary foods around 6 months of 
age leads to more gut microbial diversity.
(10) Gestation at birth: prematurity is associated with a fourfold 
increased risk of SIDS (137) as well as a dysbiotic intesti-
nal flora, and impaired gut mucosal barrier function and 
permeability (155–161). Lactobacillus GG has been shown 
to decrease the frequency of Escherichia coli K1A translo-
cation in a neonatal rabbit model (162, 163). Extremely 
preterm newborns (<28 weeks) have a 5- to 10-fold higher 
incidence of microbial infections than term newborn 
(164). The preterm neonatal gut colonization is different 
from that in the healthy, full-term infant gut. Preterm ne-
onates requiring intensive care are colonized by organisms 
such as Bifidobacteria only gradually and in a delayed 
fashion. Schwiertz et al. reported similar bacterial coloni-
zation patterns in preterm infants in contrast to breast-fed, 
full-term infants. Bacterial colonization has been observed 
to be similar in different preterm neonates irrespective of 
birth weight, feeding regime, and antibiotic therapy. The 
initial colonization of the newborn GI tract is highly de-
pendent on the environment, and cross-transmission of 
bacteria is a serious problem in the hospital (165).
(11) Small for gestational age (SGA): it has been hypothesized 
that SGA infants may have a higher incidence of SIDS as 
a result of fetal hypoxia-induced decrease in brain seroto-
nergic receptors (16, 166–169).
ConClUsion
We have provided a new SIDS hypothesis whereby the right com-
position of gut flora in the early critical stage of infant development 
could possibly optimize or modulate serotonin homeostasis in 
the serotonergic cardiorespiratory/thermoregulatory brain stem 
nuclei by a direct communication via the vagal afferents as part of 
the microbiome–gut–brain axis. This may tip the balance in favor 
of a successful autoresuscitation response to an AAE during sleep. 
Investigating the role of infant microbiome using newer culture-
independent techniques as well as the developmental physiology 
and neuropathology associated with SIDS may provide more 
specific strategies than those available currently to define the at 
risk population. As Hippocrates once stated “All diseases begin 
in the gut,” research on the gut flora in at risk infants would open 
new avenues for identifying potential biomarkers and strategies 
for prevention (e.g., maternal and/or early postnatal probiotic/
synbiotic supplementation, diet changes) of SIDS (170).
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